318 results on '"Troppmair J"'
Search Results
2. Mitochondrial players as novel therapeutic options in arrhythmogenic cardiomyopathy
3. Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a [Abstract]
4. Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a [Poster]
5. Secondary metabolites of fungus Thyronectria sp. and their antifungal and anticancer activities
6. Evidence of mitochondrial alterations in primary cardiac stromal cells from arrhythmogenic cardiomyopathy hearts
7. Apoptosis Regulation by Raf, Bcl-2, and R-Ras
8. The Effect of C-raf Antisense Oligonucleotides on Growth Factor-Induced Proliferation of Hematopoietic Cells
9. v-Raf/v-Myc Synergism in Abrogation of IL-3 Dependence: v-Raf Suppresses Apoptosis
10. Role of raf-1 Protein Kinase in IL-3 and GM-CSF-Mediated Signal Transduction
11. IL-37 - a regulation relevant cytokine in liver regeneration?
12. P–423 Lower cytotoxicity: Altered natural killer cell activation in recurrent implantation failure
13. Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia
14. The Effect of Secretory Leukocyte Protease Inhibitor (SLPI) on Ischemia/Reperfusion Injury in Cardiac Transplantation
15. Die Therapie des Transplantates mit Bilirubin verbessert den kardialen Ischämie/Reperfusionsschaden
16. Analysis of exhaled breath for screening of lung cancer patients
17. Inhibition of Stress Kinase-Dependent Pro-Oxidant Signaling as a Novel Approach for the Prevention of Ischemia/reperfusion Injury (IRI).: Abstract# C1679
18. Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations
19. Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance
20. Back to the roots: the remarkable RAF oncogene story
21. Typisierung natürlicher Killerzellen bei Patientinnen mit rezidivierenden Spontanaborten und Implantationsversagen
22. Independent control of cell survival by Raf-1 and Bcl-2 at the mitochondria
23. Die Therapie des Transplantates mit Bilirubin verbessert den kardialen Ischämie/Reperfusionsschaden
24. The RAF kinase inhibitor protein acts as a novel tumor suppressor in acute myeloid leukemia: V715
25. Profiling natürlicher Killerzellen bei Patientinnen mit rezidivierenden Spontanaborten und Implantationsversagen
26. Targeting p38 kinase for the prevention of ischemia/reperfusion-induced damage during solid organ transplantation: 007
27. Protektive Effekte der Pteridine BH4 und ABH4 auf zellulären Stress im Rahmen des Ischämie-Reperfusionsschadens: 006
28. Targeting the BAG-1/Hsp70 axis to inhibit tumor growth: B5.21
29. Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations: B2.28
30. Life/death decisions in growth factor signaling: Role of mitochondrial events: B2.29
31. Differential gene expression in apoptotic 32Dcl3 cells: induction of metallothionein
32. Lipocalin-2 Regulates the Inflammatory Response During Ischemia and Reperfusion of the Transplanted Heart
33. MICE HETEROZYGOUSLY DEFICIENT FOR THE MYELIN COMPONENT P0 SHOW INCREASED ERK-PHOSPHORYLATION AND MCP-1 EXPRESSION AT INITIAL STAGES OF PRIMARILY GENETICALLY-MEDIATED DEMYELINATION
34. The Effect of C-raf Antisense Oligonucleotides on Growth Factor-Induced Proliferation of Hematopoietic Cells
35. PO-217 Tumour suppressor function of the oxidoreductase p66Shc in BRAFV600E-transformed cells
36. 52Mechanical strain upon aortic valves causes release of danger associated molecular patterns and activates innate immunity
37. Terpene ester derivatives of the roots of Ferula hezarlalehzarica
38. Plasmacytoma Induction by J Series of v-myc Recombinant Retroviruses: Evidence for the Requirement of Two (raf and myc) Oncogenes for Transformation
39. Possible Use of the Monocyte/Macrophage Activation Marker Neopterin for Clinical Monitoring of Sepsis-Related Multiorgan Failure
40. Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP
41. A compendium of volatile organic compounds (VOCs) released by human cell lines
42. The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ
43. URINARY NEOPTERIN EXCRETION IN THE FOLLOW UP OF BONE MARROW TRANSPLANT RECIPIENTS
44. INTRACELLULAR CHANGES IN PTERIN RELEASING PERIPHERAL BLOOD MONONUCLEAR CELLS AFTER STIMULATION WITH INTERFERON-GAMMA
45. DISEASE ASSOCIATED ALTERATIONS OF PTERIN BIOSYNIHESIS: ENHANCEMENT IN INFLAMMATORY DISEASE, HEMOPOIETIC REGENERATION AND ENDOTOXINEMIA
46. Clinical Effectiveness of Minimal and Atoxic Doses of Interferon Alpha for Treatment of Hairy Cell Leukemia1
47. Inhibition of Stress Kinase-Dependent Pro-Oxidant Signaling as a Novel Approach for the Prevention of Ischemia/reperfusion Injury (IRI).
48. p38MAPK Inhibition Prevents Impairment of Kidney Function Resulting from Ischemia/Reperfusion Injury (IRI)
49. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells
50. PREVENTION OF KIDNEY ISCHEMIA-REPERFUSION INJURY: ROLE OF P38 MAP KINASE INHIBITION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.